Aspen Neuroscience has been awarded an $8 million grant to advance the clinical development of ANPD001, its investigational stem…
Articles by Andrea Lobo
Enhancing mechanisms associated with the degradation of misfolded proteins at the proteasome, that is, cellular structures where these proteins are…
The first 25 patients have been enrolled in a Phase 3 trial that’s testing the light-based, at-home therapy device called…
A newly developed molecule showed an ability in lab studies to activate antioxidant responses in brain cells by altering how…
Topline efficacy data from a Phase 3 clinical trial evaluating the oral therapy buntanetap for early-stage Parkinson’s disease is…
Researchers in Canada have developed a new method to generate functional dopaminergic neurons, the dopamine-producing nerve cells lost in Parkinson’s…
After adding $47 million in new funding, Cerevance is planning to launch a Phase 3 clinical trial to test its…
People who carry a specific mutation in the RAB32 gene have a higher risk of developing Parkinson’s disease, researchers…
Cycling indoors on a stationary bicycle for two may improve the health and well-being of people with Parkinson’s disease…
Rumble Boxing, a U.S. fitness brand, is partnering for the second year with Team Fox, the grassroots fundraising community…